1. President Trump's proposal to eliminate pharmacy benefit managers (PBMs) has caused significant market uncertainty, impacting UnitedHealth (UNH) due to its PBM exposure; 2. The article analyzes potential legal and regulatory pathways for PBM reform and evaluates whether the market has overreacted to worst-case scenarios; 3. Financial estimates and investment strategies for UNH are provided, including recommendations for navigating current risks.